Clinical trial
Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind…
NCT00232258 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00232258 |
|---|---|
| Title | Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study |
| Official title | Nolpitantium Besylate in Patients With Mild to Moderate Ulcerative Colitis, a Double-Blind, Placebo Controlled Efficacy and Safety, 8 Week Study |
| Acronym | NICE |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis, Inflammatory Bowel Disease |
| Intervention type | Drug |
| Interventions | Nolpitantium besylate |
| Enrollment | 307 |
| Start date | Apr 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Dec 10, 2008 |
| Countries | Argentina, Belgium, Brazil, Canada, Chile, Czechia, Estonia, Hungary, Italy, Russia, Singapore, South Africa and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: